Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$10.47 - $16.75 $106,940 - $171,084
-10,214 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$15.36 - $25.0 $233,395 - $379,875
-15,195 Reduced 59.8%
10,214 $158,000
Q3 2021

Nov 12, 2021

BUY
$22.56 - $29.68 $253,506 - $333,514
11,237 Added 79.29%
25,409 $573,000
Q2 2021

Aug 16, 2021

BUY
$24.96 - $41.25 $353,733 - $584,595
14,172 New
14,172 $365,000

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $499M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.